CVS Health replaced its top executive as it warned that its coming earnings will once again fall short of Wall Street ...

The hits keep coming for CVS Health, which on Friday revealed new leadership and a bleaker-than-expected balance sheet. The ...

CVS Health CEO Karen Lynch has stepped down, with company shares sinking 19% this year and the health-care giant struggling on several fronts. CVS Health also warned of disappointing third-quarter ...

CVS Health Corp. named David Joyner as its new chief executive officer, ending a tumultuous tenure for Karen Lynch at the ...

CVS Health stock sold for $72.08 a share when Karen Lynch became president and CEO in 2021. It closed at $60.35 on Friday.

Taking over for Karen Lynch is pharmacy services veteran David Joyner, who rejoined the company nearly two years ago.

CVS Health on Friday replaced CEO Karen Lynch with David Joyner, a CVS veteran who retired before returning to the company ...

CVS Health has a new CEO: David Joyner, a seasoned veteran in the healthcare industry, is stepping into the challenging role.

Shares are down by nearly half from their 2022 highs, in part due to repeated profit forecast cuts related to rising costs in ...

CVS Health said Friday that as of Thursday David Joyner became its new CEO, replacing Karen Lynch. In an agreement with the ...

Only 40% of Medicare Advantage health prescription drug plans achieved a four-star rating or higher under the current criteria used by Centers for Medicare and Medicaid Services to grade quality. The ...